The 5'-terminal part of the HCV ORF encodes one nonstructural protein (the HCV autoprotease p23) and four structural proteins (the nucleocapsid protein p14 and three glycoproteins, gp44/48, gp33, and gp55). HCV gp44/48 and gp55 each form disulfide-linked homodimers, while gpS5 also dimerizes to a heterodimer with the putative transmembrane glycoprotein gp33; these dimers are present in HCV-infected cells as well as in virions (22) . It was previously shown that one of the pestiviral glycoproteins, HCV gp55/BVDV gp53, mediated neutralization (4, 25, 27) ; this feature is an indirect indication of the presence of HCV gp55/BVDV gp53 at the surface of the respective virions. We show here that the envelope glycoprotein HCV gp44/48 also induces neutralizing monoclonal antibodies (MAbs). For the first time, the localization of a pestiviral glycoprotein at the surface of virions is directly demonstrated.
strains. It is suggested that the MAbs are well suited for epidemiological investigations of HCV outbreaks.
Members of the genus Pestivirus are causative agents of animal diseases that occur worldwide, namely, hog cholera, bovine viral diarrhea, and border disease of sheep (12) . Molecular characterization of two members of the genus, bovine viral diarrhea virus (BVDV) and hog cholera virus (HCV), demonstrated that the pestivirus genome is represented by a single-stranded RNA of about 12.5 kb which is of positive polarity and comprises a single large open reading frame (ORF) (2, 3, 15, 17) . For HCV, this ORF is translated into a hypothetical polyprotein of 3,898 amino acids. The mature proteins are released from this polyprotein by virusencoded and host cell proteases.
The 5'-terminal part of the HCV ORF encodes one nonstructural protein (the HCV autoprotease p23) and four structural proteins (the nucleocapsid protein p14 and three glycoproteins, gp44/48, gp33, and gp55). HCV gp44/48 and gp55 each form disulfide-linked homodimers, while gpS5 also dimerizes to a heterodimer with the putative transmembrane glycoprotein gp33; these dimers are present in HCV-infected cells as well as in virions (22) . It was previously shown that one of the pestiviral glycoproteins, HCV gp55/BVDV gp53, mediated neutralization (4, 25, 27) ; this feature is an indirect indication of the presence of HCV gp55/BVDV gp53 at the surface of the respective virions. We show here that the envelope glycoprotein HCV gp44/48 also induces neutralizing monoclonal antibodies (MAbs). For the first time, the localization of a pestiviral glycoprotein at the surface of virions is directly demonstrated.
MATERIALS AND METHODS
Cells and viruses. The pig lymphoma cell line 38A1D was kindly provided by W. Schafer (Max-Planck-Institut fur Virusforschung, Tubingen, Germany) (21) . Cells were grown in Dulbecco's modified Eagle medium with 10% fetal calf serum. Swine testis epitheloid (STE) cells were derived from a cell clone of McClurkin's ST cell line which had been received from J. B. Derbyshire (Guelph, Ontario, Canada) (13) . The ELISA with bacterial fusion proteins. The positions of HCV clones expressed as fusion proteins in bacteria have been described elsewhere (20) . One fusion protein contains part of HCV gp44/48, whereas the second fusion protein contains part of HCV gp55. Coating of enzyme-linked immunosorbent assay (ELISA) plates and further processing of the plates were performed as described previously (25) Radioimmunoprecipitation and SDS-PAGE. Cell extracts were prepared for immunoprecipitation as described earlier (18) . For precipitation under denaturing conditions, the infected cells were disrupted by boiling with 2% SDS (7) .
The extracts were incubated with 100 Rl of hybridoma supernatant. Precipitates were formed with cross-linked Staphylococcus aureus (8) , analyzed by SDS-PAGE (12% polyacrylamide) (5) under reducing conditions, and processed for fluorography by using En3Hance (New England Nuclear). The dried gels were exposed to Kodak XAR5 X-ray films at -70°C. The 14C-labeled molecular weight standards were from Amersham Buchler.
Immunogold electron microscopy. STE cells infected in suspension with HCV were grown as monolayers on multitest slides. At 24 h after infection, they were incubated without previous fixation sequentially with MAb 24/16, rabbit anti-mouse IgG (Dianova), and protein A-colloidal gold particles (8 nm Immunoperoxidase assay. STE cells were seeded simultaneously with different HCV isolates in microtiter plates at a multiplicity of infection such that all cells in a plate were uniformly infected after 3 days. After incubation for 3 or 4 days at 37°C, the supernatants were discarded. The cells were washed once with PBS diluted 1/3 in water, dried, fixed with a mixture of acetone and methanol for 10 min, and dried again. Each well then received 50 ,ul of a 1:10 dilution of different MAb hybridoma supernatants. The plates were incubated for 2 h at 37°C. After discarding of the supernatants and thorough washing with PBS plus 0.05% Tween-20, 50 ,ul of a rabbit anti-mouse IgG peroxidase conjugate was added, and the plates were again incubated for 1 h, followed by washing three times with PBS-Tween and once with water. Aminoethyl carbazole and H202 in sodium acetate buffer (pH 5.0) served as substrate in the staining reaction, which lasted up to 30 min. Excess substrate was removed, and 50 ,ul of water per well was added. with myeloma cells, the first screening was performed by immunofluorescence on noninfected and HCV-infected STE cells; 66 positive hybridomas which secreted antibodies reacting only with HCV-infected cells were identified. In order to identify the proteins recognized by the hybridoma supernatants, they were first analyzed in an ELISA for reactivity with different bacterial fusion proteins encompassing parts of HCV-encoded structural proteins (20) . Several of the hybridomas reacted with the HCV gpS5-derived fusion protein, but only two hybridomas recognized the HCV gp44/48-derived polypeptide. It was assumed that the latter represented antibodies able to recognize denatured gp44/48. These two hybridoma supernatants were tested in a Western blot. Pelleted virions were separated under reducing and nonreducing conditions (Fig. 1) ; both conditions were applied because HCV gp44/48 is found in virions in a monomeric and a disulfide-linked homodimeric form (size, about 100 kDa) (22) . The two hybridoma supernatants recognized the HCV gp44/48 monomer (Fig. 1, lanes 1 and 2) as well as the disulfide-linked gp44/48 homodimer (Fig. 1, lanes 4 and  5) . In a previous article, preparation and characterization of MAbs against HCV gp55 have been described (25) . Interestingly, the immunofluorescence with all of the anti-HCV gp55 MAbs was considerably stronger and less diffuse than that observed with the two anti-HCV gp44/48 MAbs (Fig. 2) . We assumed that the kind of fluorescence may be specific for either glycoprotein. According to this criterion, additional MAbs were isolated, representing promising candidates for recognition of HCV gp44/48. In order to identify the anti- gen(s) reactive with these MAbs, immunoprecipitation experiments with extracts from metabolically labeled HCVinfected cells were performed. To differentiate MAbs that recognize native and/or denatured protein(s), different precipitation conditions were applied. Figure 3 shows the separation of immunoprecipitated proteins obtained under native (Fig. 3A) and denaturing (Fig. 3B) (Fig. SA) . Neutralization observed with an anti-HCV gp55 MAb was, however, much stronger (Fig. 5, control) (Fig. 5B) . In contrast to the individual MAbs, the paired MAbs were able to partially neutralize 104 TCID5() of HCV Alfort. Use of all possible 27 pairs showed that anti-HCV gp44/48 MAbs (Fig. 5A, a to g) We conclude from these studies that MAbs against HCV gp44/48 represent a promising diagnostic tool for the identification of HCV isolates. that this structural glycoprotein shows a higher variability than HCV gp44/48/BVDV gp48 or HCV gp33/BVDV gp25 (25) . It therefore seemed appropriate to use the respective MAbs (against HCV gp55 and BVDV gp53, respectively) to discriminate HCV and BVDV as well as pestivirus strains. Such investigations are important for diagnostic and epidemiological studies. While BVDV and HCV are easily distinguishable by this approach, the identification of HCV strains was less satisfactory, at least with the MAbs against HCV gp55 available to us (data not shown).
To elucidate the reactivity pattern of anti-HCV gp44/48 MAbs, indirect immunoperoxidase assays were performed after infection of STE cells with different HCV strains and one BVDV isolate. 
DISCUSSION
MAbs against HCV gp44/48 were obtained by using an immunization protocol which had been applied earlier for the preparation of anti-HCV gp55 MAbs (25) . In order to obtain a panel of anti-HCV gp44/48 MAbs, different assays had to be applied. After identification of anti-HCV-producing hybridomas by indirect immunofluorescence, an ELISA against a bacterial fusion protein which encompassed part of the HCV gp44/48 region was employed. Two positive supernatants from hybridoma cells were isolated in this way. A Western blot analysis confirmed reactivity with HCV gp44/ 48, because these two hybridoma supernatants recognized monomeric as well as disulfide-linked dimeric gp44/48. The observation that immunofluorescence patterns on HCVinfected cells with previously characterized anti-HCV gp55 MAbs and these two anti-HCV gp44/48 MAbs were quite different facilitated the identification of additional anti-HCV gp44/48 MAbs. The reason for the different fluorescence patterns observed with MAbs against these two HCV envelope glycoproteins is not known. It apparently does not reflect a lower degree of avidity of the anti-HCV gp44/48 MAbs, since in immunoprecipitation experiments from cell extracts no difference among the MAbs against both glycoproteins has been found. In addition, the distribution of antibody subclasses is similar for both groups of MAbs. HCV gp44/48 is supposed to start with amino acid 268 of the predicted ORF just behind a typical signal sequence with Ala and Val in positions -1 and -3, respectively (22, 24) . The C terminus has been predicted to be amino acid 485 (20) . According to these assumptions, stretches of hydrophobic amino acids necessary for membrane anchoring are missing within gp44/48. A partial loss of HCV gp44/48 from the membranes of infected cells may therefore result in the specific fluorescence pattern. N-terminal protein sequencing of purified pestivirus glycoproteins HCV gp44/48 and gp33 will be performed to determine directly whether gp44/48 lacks an effective membrane anchor.
The demonstration of gp44/48 at the surface of virions and the successful neutralization experiments with anti-HCV gp44/48 MAbs indicate that this pestiviral glycoprotein is a candidate to contribute to protection in the natural host. In a previous study, we investigated the role of different proteins for induction of a protective immune response using the vaccinia virus expression system (19) . The experiments showed that expression of the four structural proteins-HCV p14, gp44/48, gp33, and gp55-by a recombinant vaccinia virus induced protective immunity in pigs against a lethal dose of HCV. Interestingly, pigs immunized with a vaccinia virus/HCV recombinant lacking most of the HCV gp55 coding sequences were also protected against a lethal challenge (19). Our failure to detect neutralizing antibodies in animals immunized with the respective vaccinia virus/ HCV recombinant could be explained by low titers of the induced antibodies which were not detected by a standard neutralization assay. The development of effective vaccines against hog cholera should not be restricted to the structural glycoprotein HCV gp55 (23) . As 
